Polymorphic Cytochromes P450 and Drugs Used in Psychiatry
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 19 (3) , 325-354
- https://doi.org/10.1023/A:1006945715127
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- “It's the genes, stupid” Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphismLife Sciences, 1995
- Human cytochrome P-450 enzymesLife Sciences, 1992
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypesPharmacogenetics, 1991
- Clinical Pharmacokinetics of ClomipramineClinical Pharmacokinetics, 1991
- Fluoxetine‐Induced Tricyclic Toxicity: Extent and DurationThe Journal of Clinical Pharmacology, 1991
- Recent Developments in Hepatic Drug OxidationClinical Pharmacokinetics, 1990
- Influences of Diet and Nutrition on Clinical PharmacokineticsClinical Pharmacokinetics, 1988
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982